What is Microconsult?
Microconsult operates as a critical infrastructure provider for the pharmaceutical, cosmetic, and medical device industries. The firm specializes in rigorous analytical testing, utilizing industry-standard protocols such as USP, AOAC, and ASTM to ensure product safety and regulatory compliance. Beyond standard testing, the company distinguishes itself through bespoke method development and validation, providing a turnkey solution for manufacturers navigating complex shelf-life and stability requirements. With state-of-the-art on-site stability chambers and a commitment to rapid turnaround times, Microconsult serves as an essential partner for organizations aiming to expedite their time-to-market while maintaining stringent quality control standards.
How much funding has Microconsult raised?
Microconsult has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Microconsult
PPP
Public-Private Partnership
What's next for Microconsult?
With the infusion of this recent capital, Microconsult is poised to scale its laboratory operations and enhance its technical capabilities. The strategic focus will likely center on increasing throughput for microbiological and chemical assays, further reducing lead times for clients in the OTC drug and nutritional product sectors. As the regulatory landscape for medical devices and consumer health products continues to evolve, Microconsult's investment in advanced analytical equipment and personnel will be pivotal in maintaining its competitive edge. The company is expected to leverage this financial backing to solidify its reputation as a premier partner for end-to-end product stability and quality assurance testing.
See full Microconsult company page
